We are live on
!
Find out more
NL
Navalign LLC Portfolio holdings
AUM
$429M
1-Year Est. Return
18.12%
This Quarter
Est. Return
+2.25%
1 Year Est. Return
+18.12%
3 Year Est. Return
+50.7%
5 Year Est. Return
+57.4%
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$28.4M
(+7.5%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
52.74%
Holding
512
New
387
Increased
60
Reduced
39
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Quality Factor ETF
JQUA
|
+$7.59M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$2.39M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$839K |
| 4 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$789K |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$750K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$3.86M |
| 2 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$909K |
| 3 |
NVIDIA
NVDA
|
+$367K |
| 4 |
Eli Lilly
LLY
|
+$191K |
| 5 |
Broadcom
AVGO
|
+$188K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.55% |
| 2 | Healthcare | 5.47% |
| 3 | Financials | 4.88% |
| 4 | Communication Services | 3.64% |
| 5 | Industrials | 3.27% |
Similar funds
BP
LJAF
CSNH
OA
RCWVOTCITCONY
MAM
GPGA
WPW
Navalign LLC's Q4 2025 Portfolio in Review
As of Q4 2025, Navalign LLC held 512 positions worth $407M, up 7.5% from $379M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Navalign LLC deployed $21.5M of net new capital in Q4 2025, opening 387 new positions and adding to 60 existing holdings. Its largest new stake was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $3.86M trimmed.
- Navalign LLC's largest Q4 2025 buy was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
- Navalign LLC added most to Fidelity Total Bond ETF in Q4 2025, an estimated $2.39M increase.
- Navalign LLC's biggest Q4 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $3.86M.
- Navalign LLC fully exited Cue Biopharma in Q4 2025, selling an estimated $18K.
- Navalign LLC's ten largest holdings make up 53% of its $407M portfolio in Q4 2025.
- Navalign LLC opened 387 new positions and closed 1 in Q4 2025.
- Navalign LLC's portfolio value rose 7.5% quarter-over-quarter to $407M.
Based on Navalign LLC's 13F filing for Q4 2025, filed 5 Feb 2026.